Skip to main content
. Author manuscript; available in PMC: 2021 Apr 1.
Published in final edited form as: Mult Scler. 2019 Sep 19;26(4):421–432. doi: 10.1177/1352458519876031

Table 2:

Atypical features for MS diagnosis, i.e. “red flags”,

Red flags Patients
Red flag type Red flags (ID) # patients (%)
Clinical
Age at symptoms onset >50 years old C(1) 7 (18%)
History of SAD C(2) 6 (15%)
History of oral/genital aphthosis or VT C(3) 5 (13%)
Poor recovery or bilateral ON C(4) 4 (10%)
Uveitis and/or retinal vasculitis C(5) 4 (10%)
Hearing loss and branch retinal artery occlusion C(6) 1 (3%)
Cognitive decline at onset C(7) 1 (3%)
Minor C(8) 6 (15%)
Laboratory
Absence of OCB L(1) 14 (36%)
Abnormal biomarkers of SAD L(2) 12 (31%)
Proteinorrachia >100 mg/dL L(3) 4 (10%)
Positive IgM Borrelia burgdoferi serology L(4) 1 (3%)
Imaging
Atypical morphology*/distribution WM lesions I(1) 12 (31%)
Longitudinal extensive transverse myelitis I(2) 3 (8%)
Diffuse meningeal contrast enhancement I(3) 3 (8%)
Absence of ≥ 2 spinal cord MRI lesions in OCB negative suspected PPMS I(4) 3 (8%)

Abbreviations: SAD: systemic inflammatory/autoimmune disorder; VT: venous thrombosis; ON: optic neuritis; OCB: CSF specific oligoclonal bands; RRMS: relapsing remitting MS; PPMS: primary progressive MS; Minor (i.e. “minor” red flags): spondyloarthritis, fibromyalgia, Raynaud’s phenomenon and history of joint inflammation with good response to corticosteroids.

*

including large brainstem lesions.